Regulation - Research, Mergers & Acquisitions

Filter

Popular Filters

News briefs from Alimera on Iluvien and Xencor on Xtend; Galapagos milestone and acquisition

17-01-2013

US biopharma company Alimera Sciences (Nasdaq: ALIM) says that the Spanish Agency of Drugs and Medical…

Alimera SciencesBiotechnologyCangenixGalapagosIluvienJanssenJohnson & JohnsonMergers & AcquisitionsOphthalmicsPharmaceuticalRegulationResearchXencorXtend

News briefs: GlaxoSmithKline and Bayer

24-05-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) has said it would not proceed with its $2.59 billion hostile…

Antibiotics and Infectious diseasesBayerGlaxoSmithKlineMergers & AcquisitionsOncologyPharmaceuticalregorafenibRegulationResearch

Back to top